New Enterprise Associates 16, L.P.
CIK 1694560 · last filed 2025-10-06
New Enterprise Associates 16, L.P. is a corporate insider who has filed 10 SEC Form 4 insider transactions across 6 companies since 2019. The most recent filing, for BHG, was dated Oct 6, 2025. Across all open-market trades the lifetime net is +$19.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $352.8M across reported positions. The firm reports its address in Timonium, MD. 32 SEC filings were submitted jointly with NEA 16 GP, LLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AKUS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 600
TIMONIUM, MD 21093
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NeueHealth, Inc. (BHG) Delisted | Director | 787,979 | $16.35 | $12.88M | -$1.9K | 1 | 2025-10-06 |
| NeueHealth, Inc. (NEUE) Delisted | 10%+ Owner | — | $6.75 | — | $0 | 1 | 2024-04-10 |
| MIRM | 10%+ Owner | 2,186,243 | $94.97 | $207.64M | $0 | 1 | 2023-06-15 |
| TRVI | 10%+ Owner | 10,421,428 | $13.93 | $145.17M | $5.00M | 3 | 2022-04-13 |
| Regulus Therapeutics Inc. (RGLS) Delisted | 10%+ Owner | 645,106 | $8.16 | $5.26M | $3.96M | 3 | 2020-12-07 |
| Akouos, Inc. (AKUS) Delisted | 10%+ Owner | 513,758 | $13.29 | $6.83M | $10.00M | 1 | 2020-07-01 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-06 | NeueHealth, Inc. (BHG) Delisted | Mixed | −599,064 | $5 | EDGAR |
| 2024-04-10 | NeueHealth, Inc. (NEUE) Delisted | Buy (P) | — | $0 | EDGAR |
| 2023-06-15 | MIRM | Other (J) | −2,000,000 | $0 | EDGAR |
| 2022-04-13 | TRVI | Buy (P) | +2,631,578 | $5.00M | EDGAR |
| 2021-10-19 | TRVI | Buy (P) | +1,851,852 | $0 | EDGAR |
| 2020-12-07 | Regulus Therapeutics Inc. (RGLS) Delisted | Buy (P) | +4,398,602 | $2.74M | EDGAR |
| 2020-07-01 | Akouos, Inc. (AKUS) Delisted | Mixed | +4,294,207 | $10.00M | EDGAR |
| 2020-04-13 | TRVI | Mixed | +1,499,436 | -$0 | EDGAR |
| 2019-12-26 | Regulus Therapeutics Inc. (RGLS) Delisted | Buy (P) | — | $0 | EDGAR |
| 2019-05-09 | Regulus Therapeutics Inc. (RGLS) Delisted | Buy (P) | +1,136,704 | $1.23M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.